These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17584058)

  • 1. Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance.
    Danese S; Pagano N; Angelucci E; Stefanelli T; Repici A; Omodei P; Daperno M; Malesci A
    Curr Med Chem; 2007; 14(14):1489-97. PubMed ID: 17584058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of Crohn's disease.
    Van Deventer SJ
    Scand J Immunol; 2000 Jan; 51(1):18-22. PubMed ID: 10632971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TNF antibody treatment of Crohn's disease.
    van Deventer SJ
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's disease.
    Shetty A; Forbes A
    Am J Pharmacogenomics; 2002; 2(4):215-21. PubMed ID: 12421092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Crohn's disease with anti-TNF alpha].
    Lémann M
    Rev Prat; 1998 May; 48(10):1049-50. PubMed ID: 9781146
    [No Abstract]   [Full Text] [Related]  

  • 7. Review article: biological agents in the treatment of Crohn's disease.
    Caprilli R; Viscido A; Guagnozzi D
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1579-90. PubMed ID: 12197837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.
    Van den Brande JM; Braat H; van den Brink GR; Versteeg HH; Bauer CA; Hoedemaeker I; van Montfrans C; Hommes DW; Peppelenbosch MP; van Deventer SJ
    Gastroenterology; 2003 Jun; 124(7):1774-85. PubMed ID: 12806611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor necrosis factor-alpha (TNF-alpha) treatment strategies in Crohn's disease.
    Reimund JM; Ratajczyk J; Sola B; Justum AM; Muller CD
    Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):21-34. PubMed ID: 19075963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour necrosis factor therapy in Crohn's disease.
    Tilg H; Kaser A
    Expert Opin Biol Ther; 2002 Oct; 2(7):715-21. PubMed ID: 12387670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
    Baert FJ; D'Haens GR; Peeters M; Hiele MI; Schaible TF; Shealy D; Geboes K; Rutgeerts PJ
    Gastroenterology; 1999 Jan; 116(1):22-8. PubMed ID: 9869598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.
    Brown SJ; Abreu MT
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):160-8. PubMed ID: 15782540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 antibody treatment in Crohn's disease.
    Stronkhorst A; Tytgat GN; van Deventer SJ
    Scand J Gastroenterol Suppl; 1992; 194():61-5. PubMed ID: 1298050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S; Kamm MA
    Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-TNF therapy for Crohn's disease.
    D'Haens G
    Curr Pharm Des; 2003; 9(4):289-94. PubMed ID: 12570820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab induced T lymphocyte apoptosis in Crohn's disease.
    van den Brande J; Hommes DW; Peppelenbosch MP
    J Rheumatol Suppl; 2005 Mar; 74():26-30. PubMed ID: 15742461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn's disease: a case report.
    Principi M; Di Leo A; Ingrosso M; Pisani A; Marangi S; Amoruso A; Panella C; Francavilla A; Ierardi E
    Immunopharmacol Immunotoxicol; 2004 May; 26(2):243-8. PubMed ID: 15209360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Necrosis Factor's Pathway in Crohn's Disease: Potential for Intervention.
    Pagnini C; Cominelli F
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-TNF antibodies in the treatment of intestinal inflammatory disease].
    Hinojosa J
    Gastroenterol Hepatol; 2000 May; 23(5):250-7. PubMed ID: 10902280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.